Is simethicone safe in patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 25, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Simethicone is safe for use in individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency. This over-the-counter medication, which helps relieve gas and bloating by breaking up gas bubbles in the digestive tract, does not undergo significant systemic absorption and works locally in the gastrointestinal system. Unlike medications that can trigger hemolytic anemia in G6PD-deficient patients (such as certain antimalarials, antibiotics, and NSAIDs), simethicone has no oxidative properties that would stress red blood cells or deplete glutathione.

The typical adult dosage is 40-125 mg taken after meals and at bedtime, up to four times daily, with a maximum of 500 mg daily. For infants and children, dosing is typically 20-40 mg up to four times daily. Since simethicone is not metabolized by the body and passes through the digestive system unchanged, it poses no risk of hemolysis in G6PD-deficient individuals, making it a safe option for gas relief in this population. According to the most recent study 1, G6PD deficiency is estimated to affect more than 400 million people worldwide, and certain medications can cause hemolytic anemia in these individuals. However, simethicone is not listed as one of the medications that can trigger hemolytic anemia in G6PD-deficient patients.

Key points to consider:

  • Simethicone works locally in the gastrointestinal system and does not undergo significant systemic absorption.
  • It has no oxidative properties that would stress red blood cells or deplete glutathione.
  • The typical adult dosage is 40-125 mg taken after meals and at bedtime, up to four times daily, with a maximum of 500 mg daily.
  • Simethicone is not metabolized by the body and passes through the digestive system unchanged, posing no risk of hemolysis in G6PD-deficient individuals. As stated in the study 2, many compounds have been wrongly cited as causing haemolysis because they were administered to patients experiencing an infection-related haemolytic episode, and simethicone is not one of the medications that should be avoided in individuals with G6PD deficiency.

References

Related Questions

What are the cardiac risks in patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency?
Is Motilium (Domperidone) safe in patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency?
Can clarithromycin be given to a patient with Glucose-6-phosphate dehydrogenase (G6PD) deficiency?
Can Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency play a role in a 28-year-old male with elevated liver enzymes, specifically Alanine Transaminase (ALT) of 99, Aspartate Transaminase (AST) of 38, and Alkaline Phosphatase (Alka Fos) of 119, and alkaline urine pH of 8.5?
What is the most likely cause of hemolytic anemia, as evidenced by severe anemia, dark urine, and elevated total bilirubin, in a patient who recently started intravenous ceftriaxone (Ceftriaxone) and azithromycin (Azithromycin)?
What is the management for a female patient with a history of cholelithiasis (gallstones) presenting with severe abdominal pain, fever, a right hypochondrial mass, mild jaundice, and leukocytosis?
Is itotropium (Itotropium) safe in patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency?
What is the management for a child with a lingual thyroid (ectopic thyroid tissue) and no visible thyroid tissue in the neck that has become enlarged?
What is the best treatment approach for a patient with a 1.2 cm anal fistula, presenting with purulent soiling for 2 months, and an internal opening at the mid-posterior region, as shown on MRI?
What is the next step in management for a 30-year-old woman with breast pain, a family history of breast cancer (mother and sister died at 40 years old), and a normal mammogram (mammography) result?
What is the next step in management for a 30-year-old woman with a family history of breast cancer, who presents with breast pain and has a normal mammogram, with her mother and sister having died of breast cancer at 40 years old?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question